RWLK REWALK ROBOTICS LTD

Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025

Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025

MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it will host a virtual Investor Event on Thursday, February 20, 2025, beginning at 10:00 am EST. The event will feature presentations and question-and-answer sessions by members of the executive leadership team on the Company's strategy, key initiatives, and financial outlook. To register for the webcast,

In addition, the event will highlight innovative products from the Lifeward portfolio, including the ReWalk Exoskeleton, which addresses unmet medical needs for people with spinal cord injuries, and the AlterG Anti-Gravity System, standard of care for rehabilitation of a broad range of orthopedic and neurological conditions.

The Investor Event will be held virtually with a webcast available for investors, analysts, the media, and other interested parties who wish to join. The live webcast and subsequent replay of the event will be available on the Investor Relations section of the Lifeward website at .

About Lifeward

Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the MyoCycle FES System, and the ReStore Exo-Suit.

Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward product portfolio, please visit .

Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.

Lifeward Media Relations:

Kathleen O’Donnell

VP Marketing & New Business Development

Lifeward Ltd.

E:



Lifeward Investor Contact:

Mike Lawless

Chief Financial Officer

Lifeward Ltd.

E: 



EN
04/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on REWALK ROBOTICS LTD

 PRESS RELEASE

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add C...

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region Expansion adds additional AlterG dealer coverage to 6 countries throughout the Gulf Cooperation Council region MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the expansion of its relationship with SportsMed Produ...

 PRESS RELEASE

Lifeward Announces Closing of $2.6 Million Public Offering

Lifeward Announces Closing of $2.6 Million Public Offering MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the closing of its previously announced public offering of an aggregate of 4,000,000 of the Company’s ordinary shares and accompanying warrants to purchase up to 4,000,000 of the Company’s ordinary shares, at a combined public offering price of $0.65 per ...

 PRESS RELEASE

Lifeward Announces Pricing of $2.6 Million Public Offering

Lifeward Announces Pricing of $2.6 Million Public Offering MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the pricing of a public offering of an aggregate of 4,000,000 of the Company’s ordinary shares and accompanying warrants to purchase up to 4,000,000 of the Company’s ordinary shares, at a combined public offering price of $0.65 per ordinary share and assoc...

 PRESS RELEASE

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Re...

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary Decision at the highest levels of appeal in the Medicare process establishes medical necessity of the ReWalk Exoskeleton for enabling paralyzed individuals to stand and walk in everyday environments. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) --  Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today a...

 PRESS RELEASE

Lifeward Names Mark Grant as New CEO

Lifeward Names Mark Grant as New CEO Industry veteran brings 30 years of commercial leadership experience MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Mark Grant has been appointed as the Company’s new President and Chief Executive Officer, effective June 2, 2025. Larry Jasinski, Lifeward’s outgoing CEO, will serve as Co-CEO and, as previously announc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch